0.00Open0.02Pre Close0 Volume805 Open Interest75.00Strike Price0.00Turnover1277.00%IV6.11%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.02Extrinsic Value100Contract SizeAmericanOptions Type-0.0200Delta0.0179Gamma3993.00Leverage Ratio-23.7629Theta0.0000Rho-79.77Eff Leverage0.0001Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet